Enap-Co 20,0/12,5 mg Tablets.
PDF Leaflet Revision Date: 11 October 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of hypertension in patients stabilized on individual components.
Dosage (summary)
1 tablet once daily, may increase to 2 tablets if necessary.
Special Populations
- Renal impairment
- Elderly
Pregnancy & Breastfeeding
Contraindicated in pregnancy; not recommended during breastfeeding.
Key Drug Interactions
- Lithium
- NSAIDs
- Potassium-sparing diuretics
- Aliskiren
Contraindications
- Hypersensitivity
- Angioedema history
- Severe renal impairment
- Bilateral renal artery stenosis
- Severe hepatic impairment
Common side effects
- Cough
- Dizziness
- Hypotension
- Fatigue
Counselling Points
- Monitor for signs of hypotension
- Avoid potassium supplements
- Report any skin lesions
Serious warnings
- Angioedema risk
- Hypotension in volume-depleted patients
- Renal function monitoring required
Important Disclaimer
The Enap-Co 20,0/12,5 mg Tablets. professional information leaflet below is the property of Pharma Dynamics and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
